Search for another bill
Search for another bill or initiative
SB 5020 - 2021-22
Assessing a penalty on unsupported prescription drug price increases to protect the safety, health, and economic well-being of Washington residents.
Bill history
2021 Regular Session
In the Senate
Dec 17
Prefiled for introduction.
Jan 11
First reading, referred to Health & Long Term Care.
(View original bill)
Jan 22
Public hearing in the Senate Committee on Health & Long Term Care at 8:00 AM.
(Committee materials)
Feb 12
Executive action taken in the Senate Committee on Health & Long Term Care at 8:00 AM.
(Committee materials)
HLTC - Majority; 1st substitute bill be substituted, do pass.
(View 1st substitute)
(Majority report)
Minority; do not pass.
(Minority report)
Minority; without recommendation.
(Minority report)
And refer to Ways & Means.
Feb 15
Referred to Ways & Means.
2022 Regular Session
In the Senate
Jan 10
By resolution, reintroduced and retained in present status.
Available documents
For a complete list of documents, go to Detailed Legislative Reports Text of a legislative document.
Fiscal note
Amendments
Available videos